May 19,2021

Novartis to unveil new data at ASCO and EHA from its robust portfolio, including overall survival in prostate and breast cancer

Novartis will present new data from its portfolio of approved and investigational targeted, radioligand, cell and gene and immunotherapies at the upcoming 2021 American Society of Clinical Oncology (ASCO) Annual Meeting and the 2021 European Hematology Association (EHA) Virtual Congress.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
May 28,2021

COTA Healthcare's Abstracts Accepted for Publication at ASCO 2021

The ASCO Annual Meeting, presented online on June 4-8, brings together one of the largest audiences to present the latest and most innovative research in oncology. Three abstracts submitted by COTA and various collaborators have been accepted for publication at this year’s meeting.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 11,2021

How an app Mika helps fighting breastcancer

Mika, as featured in the Bild, is supported by the Berlin Charité, the National Center for Tumor Diseases Heidelberg (NCT) and the University Hospital Leipzig. The Mika app provides tips via a keyword search. What else the app can do: It can be used as a cancer diary, provides information on therapy and nutrition as well as financial tips (e.g. on applying for exemption from co-payments for medication) and helps with information or simply with relaxing music if you have to wait a long time seeking help with chemotherapy.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 22,2021

Vinehealth shortlisted for MedTech 50 innovators by Business Cloud

Vinehealth are excited to be shortlisted among 109 other startups and companies for MedTech 50 innovators by Business Cloud. This award celebrates the UK’s most innovative startups and established firms that help to diagnose and treat various conditions.

View Analyst & Ambassador Comments
Go to original news
Jun 22,2021

Vinehealth featured in Pf magazine as a solution changing behaviours, transforming lives.

Vinehealth are featured in Pf magazine as a startup to watch among solutions that change behaviours transforming lives. “Vinehealth, a mobile app supporting cancer patient through their treatment to #BeInControl. With Vinehealth, users are able to better track, manage, and understand their cancer care – something Vinehealth’s research found to be a significant pain point while going through treatment.”

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jun 24,2021

GE Healthcare and Wayra select Vinehealth and other five AI-led healthtech start-ups for EMEA Edison Accelerator

Six healthtech start-ups, including Vinehealth, have officially become the first cohort of the Edison Accelerator in EMEA – a healthcare start-up and scale-up acceleration programme designed by GE Healthcare in partnership with innovation organisation Wayra UK. The start-ups all focus on applying AI to augment medical imaging, improve oncology care and improve the patient experience. The selected start-ups were chosen as they demonstrated innovative and scalable solutions to pressing problems in the healthcare sector such as scarcity of diagnostic resources, bottlenecks in care pathways and limitations in patient input.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jun 22,2021

Real-World Data Providing Insights on Patient Management, Treatment Experience

Collecting and analyzing real-world data helps to both better understand disease and monitor medical practice and overall care with the aim of improving outcomes for patients. New real-world evidence from three clinical practice studies presented at ASCO showed how physicians play important roles in patient well-being that go beyond cancer treatment itself. The presented studies provided insights into important issues affecting breast cancer patients, including BRCA testing, financial toxicity, and treatment delays.

PRODUCT

#mobile app

#rwd

View Analyst & Ambassador Comments
Go to original news
Jun 04,2021

Information received by App influences clinical trials participation -ASCO

Dr Daniel Vorobiof speaks to ecancer about real-world evidence with the use of a specialised digital health platform. Initially, he explains the background and methodology of the study. He explains that clinical trials participation is both crucial for medical advancement and an important treatment option, at times the only one, for oncological patients. However, only an estimate of 3% of cancer patients worldwide enrol into such trials.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jun 09,2021

Philips and Elekta Deepen Strategic Partnership in Precise and Individualized Oncology Care

Royal Philips (NYSE: PHG, AEX: PHIA), and Elekta (EKTA-B.ST) signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions The extended collaboration builds on the two companies’ successful cooperation in the fast-emerging field of magnetic resonance (MR)-guided adaptive radiation therapy. Through deeper cross-portfolio collaboration, Philips and Elekta will utilize their complementary capabilities to further improve patient care.

COLLABORATION PARTNERSHIP

#r&d

#ai/software

View Analyst & Ambassador Comments
Go to original news
Jun 07,2021

Perceptions and acceptance of telemedicine among medical oncologists before and during the COVID-19 pandemic in Turkey

As a result of technological developments in healthcare services, telemedicine is becoming widespread. The study aimed to determine the effect of COVID-19 on Turkish medical oncologists’ opinions of telemedicine through a survey.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY